EUVIMEDOpdag EUVIMED
Übersichtsarbeit

COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms

Yu Zheng, Yuke Li, Mao Li, Rujing Wang, Yuhong Jiang, Mengnan Zhao, Jun Lu, Rui Li, Xiaofang Li, Sanjun Shi iD

Medicinal Research Reviews · 2024-03 · 44 (2) · 738-811

DOI: 10.1002/med.21997 ↗

At a glance

Übersichtsarbeit in Medicinal Research Reviews, published online on 2023-11-21. Written by Yu Zheng and 9 co-authors. Institution: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Chi…. Major MEDLINE topics: COVID-19, Vaccines. Cited 18 times so far (Crossref); 369 references. Funded by: Outstanding Young Scientific Talent Foundation of Sichuan Province, Science and Technology Department of Sichuan Province, State Administration of Traditional Chinese Medicine of the People's Republic of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

As severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants continue to wreak havoc worldwide, the “Cytokine Storm” (CS, also known as the inflammatory storm) or Cytokine Release Syndrome has reemerged in the public consciousness. CS is a significant contributor to the deterioration of infected individuals. Therefore, CS control is of great significance for the treatment of critically ill patients and the reduction of mortality rates. With the occurrence of variants, concerns regarding the efficacy of vaccines and antiviral drugs with a broad spectrum have grown. We should make an effort to modernize treatment strategies to address the challenges posed by mutations. Thus, in addition to the requirement for additional clinical data to monitor the long‐term effects of vaccines and broad‐spectrum antiviral drugs, we can use CS as an entry point and therapeutic target to alleviate the severity of the disease in patients. To effectively combat the mutation, new technologies for neutralizing or controlling CS must be developed. In recent years, nanotechnology has been widely applied in the biomedical field, opening up a plethora of opportunities for CS. Here, we put forward the view of cytokine storm as a therapeutic target can be used to treat critically ill patients by expounding the relationship between coronavirus disease 2019 (COVID‐19) and CS and the mechanisms associated with CS. We pay special attention to the representative strategies of nanomaterials in current neutral and CS research, as well as their potential chemical design and principles. We hope that the nanostrategies described in this review provide attractive treatment options for severe and critical COVID‐19 caused by CS.

Subjects

MeSH terms (MEDLINE)

COVID-19VaccinesHumansCytokine Release SyndromeSARS-CoV-2Critical IllnessCytokinesAntiviral Agents

Author keywords

COVID-19cytokine stormnanomedicinessevere and critical symptomstherapeutic target

Substances

CytokinesVaccinesAntiviral Agents

Authors and institutions

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Health Management Centre, Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China.
  • School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.

ORCID profiles: Sanjun Shi

Funding

  • Outstanding Young Scientific Talent Foundation of Sichuan Province
  • Science and Technology Department of Sichuan Province
  • State Administration of Traditional Chinese Medicine of the People's Republic of China
  • Sichuan Administration of Traditional Chinese Medicine
  • The Project of High-level Talents in Sichuan Province
  • National Natural Science Foundation of China

Cite

APA

Zheng, Y., Li, Y., Li, M., Wang, R., Jiang, Y., Zhao, M., Lu, J., Li, R., Li, X., & Shi, S. (2024). COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms. Medicinal Research Reviews, 44(2), 738-811. https://doi.org/10.1002/med.21997

Vancouver

Zheng Y, Li Y, Li M, Wang R, Jiang Y, Zhao M, et al. COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms. Medicinal Research Reviews. 2024;44(2):738-811. doi:10.1002/med.21997

BibTeX
@article{Zheng2024,
  author = {Zheng, Yu and Li, Yuke and Li, Mao and Wang, Rujing and Jiang, Yuhong and Zhao, Mengnan and Lu, Jun and Li, Rui and Li, Xiaofang and Shi, Sanjun},
  title = {COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms},
  journal = {Medicinal Research Reviews},
  year = {2024},
  volume = {44},
  number = {2},
  pages = {738--811},
  doi = {10.1002/med.21997}
}
Start for free →